NexgenRx Inc.
NEGXF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $14,223 | $19,234 | $19,950 | $20,400 |
| - Cash | $23,374 | $2,134 | $1,896 | $1,706 |
| + Debt | $298 | $437 | $508 | $534 |
| Enterprise Value | -$8,853 | $17,537 | $18,563 | $19,228 |
| Revenue | $3,017 | $4,346 | $4,551 | $3,939 |
| % Growth | -30.6% | -4.5% | 15.5% | – |
| Gross Profit | $2,242 | $3,561 | $3,624 | $3,372 |
| % Margin | 74.3% | 81.9% | 79.6% | 85.6% |
| EBITDA | $662 | $661 | $826 | $744 |
| % Margin | 22% | 15.2% | 18.2% | 18.9% |
| Net Income | $423 | $354 | $527 | -$28 |
| % Margin | 14% | 8.1% | 11.6% | -0.7% |
| EPS Diluted | 0.006 | 0.005 | 0.006 | -0 |
| % Growth | 12% | -16.7% | 1,600% | – |
| Operating Cash Flow | -$1,613 | $1,040 | $353 | $241 |
| Capital Expenditures | -$3 | -$342 | -$55 | -$99 |
| Free Cash Flow | -$1,615 | $699 | $297 | $142 |